Pakistan Class D Design Examination Certificate

1. Key takeaways

Conformity assessment for Class D devices in Pakistan carries one more tier than Class B and C: in addition to quality management system certification issued by a notified body, a design examination certificate for the device must also be provided. The practical checklist corresponds to the EC design examination certificate. This additional requirement makes Class D the tier with the highest registration threshold in Pakistan. The extra tier is not a formality layered onto the same evidence; it engages a different body of work altogether, the design history of the device rather than the management of its production. A manufacturer can hold a flawless quality system certificate and still have nothing in hand that answers the design examination expectation, which is why Class D projects in Pakistan so often turn on a single question asked early: does design examination evidence already exist, and if not, how will it be obtained before the submission window opens?

It helps to see the requirement from the regulator’s side as well. A quality management system certificate says that a manufacturer runs controlled processes; it does not, by itself, say that any particular device was designed correctly. For the highest-risk class, the rules decline to rely on process control alone and demand evidence that reaches back into the design itself. The design examination certificate is that evidence, delivered through the one channel the rules recognise for it, examination by a notified body. Once the logic is stated this way, the extra tier stops looking like an administrative burden and starts looking like a coherent closing of the evidential gap, and the planning question shifts from whether to obtain it to how early the work behind it can begin.

• Class B/C/D require notified-body QMS certification, and Class D additionally requires design examination.
• The practical instrument is the EC design examination certificate.
• Existing foreign quality system and product evidence must be submitted.
• Registration is evidenced by a certificate with a number, valid for 5 years.
• Rejection must be communicated with written reasons.
• Manufacturing and testing methods remain subject to the principles of verification.

2. Legal basis

The provisions below, all drawn from the Medical Devices Rules 2017 notified on 16 January 2018, trace the Class D pathway from the conformity assessment requirement through the grant of the certificate to its validity and the duty to give written reasons on rejection.

3. Expert insights

Insight one: this provision separates Class D from Class C cleanly at the level of the dossier. Class B and C need only the QMS certification; Class D additionally needs design examination. Chinese-language source material often states that the requirements for Class C and Class D are the same, and that is wrong. The confusion is understandable at first glance, because the two classes share a QMS requirement and, as noted below, even share a fee band; but the dossier demanded of a Class D device is structurally larger, and treating the two classes as identical leads to Class D projects that arrive at submission without their distinguishing evidence.

Insight two: the difficulty of the design examination certificate lies not in the certificate itself but in the documentation behind it. Design verification and validation records, risk management files and clinical evaluation materials must all form a system. Holding ISO 13485 without a design examination certificate issued by an EU notified body is the most common sticking point of Class D projects. The certificate is the visible tip of a submerged body of work: verification and validation testing, risk analysis, and clinical or performance evidence must exist, be interlinked, and be examinable. A notified body issues the certificate after examining that body of work, not instead of it, so the lead time of a Class D project is really the lead time of assembling and surviving that examination.

Insight three: Class C and Class D share a fee band, but their dossier requirements differ. Under Schedule C, the registration fee for Class C and Class D is the same band (PKR 50,000), yet Class D carries the additional element of the design examination certificate. Equal fees do not mean equal thresholds. The fee table is the most quoted part of any fee schedule and the least informative about real effort; it tells the applicant what the submission costs, not what the evidence costs. Budgeting a Class D project from the fee table alone therefore understates it, sometimes by a wide margin, and the correction belongs at the project assessment stage, not after the first deficiency letter.

4. Practical recommendations

• At the project assessment stage, list the Class D design examination evidence as a separate line item and tell the client plainly: ISO 13485 and the CE certificate are the base, and the design examination certificate is an additional tier.
• For manufacturers not yet holding that evidence, present a comparison of the cost and time of two remediation routes and let the client decide.
• Judgements of this kind must be completed before submission, because what is lost otherwise is an entire round of review.
• Verify that the design examination certificate is within its validity period and that its scope matches the device submitted.

5. Verification checklist

• □ Confirmed that Class D requires the additional design examination certificate
• □ Design verification and validation records form a coherent system
• □ Risk management files prepared
• □ Clinical evaluation materials prepared
• □ Design examination certificate within its validity period
• □ Remediation routes compared and evaluated (obtain the certificate versus change the pathway)

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Pakistan. Our team prepares dossiers to DRAP expectations, manages eCTD-format submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com